Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Rogers, Laura Q

University Of Alabama At Birmingham
United States

Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors 5R01CA235598-06 Gabriela Riscuta, M.D., CNS
Rogers, Laura Q

University Of Alabama At Birmingham
United States

Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors 5R01CA235598-06 Gabriela Riscuta, M.D., CNS
Rosenberg, Daniel William

University Of Connecticut Sch Of Med/Dnt
United States

Microbiota, Metabolites, and Colon Neoplasia 5R01CA252045-05 Amit Kumar, Ph.D.
Rosenbluth, Jennifer M.

University Of California, San Francisco
United States

In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer 4R01CA281361-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ross, Stephen

New York University School Of Medicine
United States

Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress 5R01CA268521-04 Rachel Altshuler, Ph.D.
Ross, Stephen

New York University School Of Medicine
United States

Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress 5R01CA268521-04 Rachel Altshuler, Ph.D.
Rosser, Charles J

Cedars-Sinai Medical Center
United States

A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology 5R01CA277810-03 Guillermo Marquez, Ph.D.
Rotemberg, Veronica Miriam

Sloan-Kettering Inst Can Research
United States

M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection 5U24CA264369-04 Guillermo Marquez, Ph.D.
Roth, Michael E.

Public Health Institute
United States

Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant 3UG1CA189955-11S3 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Roth, Michael E.

Public Health Institute
United States

Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant 3UG1CA189955-11S3 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rowland, Kendrith Martin

Carle Foundation
United States

Carle Cancer Center NCI Community Oncology Research Program (NCORP) 3UG1CA189861-11S1 Vanessa A. White, M.P.H.
Rowland, Kendrith Martin

Carle Foundation
United States

Carle Cancer Center NCI Community Oncology Research Program (NCORP) 3UG1CA189861-11S1 Vanessa A. White, M.P.H.
Russell, John A

University Of Wisconsin-Madison
United States

Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment 5R37CA225608-07 Cecilia Lee, Dr.P.H., RN
Russell, John A

University Of Wisconsin-Madison
United States

Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment 5R37CA225608-07 Cecilia Lee, Dr.P.H., RN
Saenger, Yvonne Margaret

Albert Einstein College Of Medicine
United States

Applying pathomics to establish a biosignature for aggressive skin melanoma 5R01CA260375-05 Guillermo Marquez, Ph.D.